Increased plasma apolipoprotein(a) levels in IDDM patients with diabetic nephropathy

Diabetes Care

Volumn 19, Issue 12, 1996, Pages 1382-1387

  Tarnow, Lise ^a   Rossing, Peter ^a   Nielsen, Flemming S ^a   Hansen, Birgitte V ^a   Dyerberg, Jørn ^b   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

^b Medi Lab a s   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY RISK; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

EID: 0029856278     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.12.1382     Document Type: Article

References (35)

1. Borch-Johnsen K, Kreiner S: Proteinuría: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 294:1651-1654, 1987
2. 1-lipoprotein in patients with coronary heart disease. Clin Genet 6:230-235, 1974
3. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL: Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256:2540-2544, 1986
4. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H: Lipoprotein(a) and coronary heart disease: a prospective case-control study in general population sample of middle aged men. Br Med J 301:1248-1251, 1990
5. Ridker PM, Hennekens CH, Stampfer MJ: A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 270:2195-2199, 1993
6. Schernthaner G, Kostner GM, Dieplinger H, Prager R, Mühlhauser I: Apolipoproteins (A-I, A-II, B) Lp(a), lipoprotein and lecithin: cholesterol acetyltransferase activity in diabetes mellitus. Arteriosclerosis 49:277-293, 1983
7. Kapelrud H, Bangstad H-J, Dahl-Jørgensen K, Berg K, Hanssen KF: Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. Br Med J 303:675-678, 1991
8. Jay RH, Jones SL, Hill CE, Richmond W, Viberti GC, Rampling MW, Betteridge DJ: Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabet Med 8:662-667, 1991
9. Jenkins AJ, Steele JS, Janus ED, Best JD: Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 40:787-790, 1991
10. Winocour PH, Bhatnagar D, Ishola M, Arrol S, Durrington PN: Lipoprotein(a) and microvascular disease in type 1 (insulin-dependent) diabetes. Diabet Med 8:922-927, 1991
11. Gall M-A, Rossing P, Hommel E, Voldsgaard AI, Andersen P, Nielsen FS, Dyerberg J, Parving H-H: Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy. Scand J Clin Lab Invest 52:513-521, 1992
12. Winocour PH, Durrington PN, Bhatnager D, Mbewu D, Ishola M, Mackness M, Arrol S: A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 18:173-184, 1992
13. Maioli M, Tonolo G, Arca GM, Brizzi P, Cherchi GM, Ciccarese M, Pacifico A, Realdi G: Lipid pattern, apolipoproteins A1 and B and lipoprotein(a) in type 1 diabetic patients with microalbuminuria. Acta Diabetol 29:246-249, 1992
14. Maser RE, Drash AL, Usher D, Kuller LH, Becker DJ, Orchard TJ: Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort. Diabetes Care 16:755-758, 1993
15. Guillausseau P-J, Peynet J, Chanson P, Legrand A, Altman J-J, Poupon J, N'Guyen M, Rousselet F, Lubetzki J: Lipoprotein(a) in diabetic patients with and without chronic renal failure. Diabetes Care 15:976-979, 1992
16. Pumell JQ, Marcovina SM, Hokanson JE, Kennedy H, Cleary PA, Steffes MW, Brunzell JD: Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM: results from follow-up in the Diabetes Control and Complications Trial. Diabetes 44:1218-1226, 1995
17. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parang H-H: Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferate retinopathy in IDDM patients. Diabetes 44:489-494, 1995
18. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borch-Johnsen K, Parving H-H: Insertion/deletion polymorphism in the angiotensin-I-convertmg enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38:798-803, 1995
19. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy Lancet i:175-1179, 1983
20. Kattermann R, Jaworek D, Möller D: Multicenter study of a new enzymatic method of cholesterol determination. J Clin Chem Biochem 22:245-251, 1984
21. Friedewald WT, Levy RI, Frederickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin Chem 18:499-502, 1972
22. 1c. Diabetes 29:623-628, 1980
23. Ullmann R, Bonitz K: Vollmechanisierte kinetische Messung von Kreatinin. Med Lab 29:137-145, 1976
24. Feldt-Rasmussen B, Dinesen B, Deckert M: Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy Scand J Clin Lab Invest 45:539-544, 1985
25. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S: The electrocardiogram in population studies: a classification system. Circulation 21:1160-1175, 1960
26. Scanu AM: Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Biochem Pharmacol 46:1675-1680, 1993
27. Ruotolo G, Zoppo A, Parlavecchia M, Giberti B, Micossi P: Apolipoprotein(a) levels in type 1 and type 2 diabetes mellitus. Acta Diabetol 28:158-161, 1991
28. James RW, Boemi M, Sirolla C, Amadio L, Fumelli P, Pometta D: Lipoprotein(a) and vascular disease in diabetic patients. Diabetologia 38:711-714, 1995
29. Császár A, Dieplinger H, Sandholzer C, Karádi I, Juhász E, Drexel H, Halmos T, Romics L, Patsch JR, Utermann G: Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus. Diabetologia 36:47-51, 1993
30. Dagen MM, Packard CJ, Shephard J: A comparison of commercial kits for the measurement of lipoprotein(a). Ann Clin Biochem 28:359-364, 1991
31. Couper JJ, Cocciolone R, Bates DJ, Nairn J, Ryall RG: Longitudinal study of lipoprotein(a) in peripubertal children with insulin-dependent diabetes. Diabet Med 12:508-512, 1995
32. Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P: Lipoprotein(a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med 117:42-47, 1992
33. Carlson LA, Hamsten A, Asplund A: Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidemic subjects treated with nicotinic acid. J Intern Med 226:271-276, 1989
34. Rossing P, Hansen BV, Nielsen FS, Myrup B, Parving H-H: Fish oil in diabetic nephropathy (DN) (Abstract). Eur J Endocrinol 132 (Suppl. 1):23, 1995
35. Thiery J, Armstrong VW, Schleef J, Creutzfeldt C, Creutzfeldt W, Siedel D: Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr 66:462-463, 1988